B. Riley Financial Varied
Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries

Agenus Inc. - Common Stock (NQ:AGEN)

3.360 -0.040 (-1.18%)
Streaming Delayed Price Updated: 1:32 PM EST, Jan 22, 2026 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

All News about Agenus Inc. - Common Stock

< Previous 1 2
...
5 6 7 8 9 10 11 12 Next >
News headline image
3 Magnificent Growth Stocks to Buy Hand Over Fist ↗
Small-cap stocks could get a boost from the central bank's anticipated rate cuts in 2025. These three stocks may be a great way to get ahead of this catalyst. 
Via The Motley Fool
Topics Economy
News headline image
FDA Grants Agenus Type B End-of-Phase 2 Meeting to Discuss BOT/BAL Therapy for Relapsed or Refractory Metastatic Colorectal Cancer
From Agenus Inc.
Via Business Wire
News headline image
Agenus (AGEN) Q1 2024 Earnings Call Transcript ↗
AGEN earnings call for the period ending March 31, 2024. 
Via The Motley Fool
Topics Earnings
News headline image
AGEN Stock Earnings: Agenus Misses EPS, Misses Revenue for Q1 2024 ↗
AGEN stock results show that Agenus missed analyst estimates for earnings per share and missed on revenue for the first quarter of 2024. 
Via InvestorPlace
News headline image
Agenus Reports First Quarter 2024 Results
From Agenus Inc.
Via Business Wire
News headline image
Up 40%: Is This Red-Hot Growth Stock Still a Buy? ↗
This small-cap biotech stock is surging. Time to buy? 
Via The Motley Fool
News headline image
Earnings Preview For Agenus ↗
 
Via Benzinga
News headline image
Ligand and Agenus Enter Into $100 Million Royalty Financing Agreement
From Ligand Pharmaceuticals Incorporated
Via Business Wire
News headline image
Agenus Regains Compliance with Nasdaq Minimum Bid Price Requirement
From Agenus Inc.
Via Business Wire
News headline image
12 Health Care Stocks Moving In Friday's Intraday Session ↗
 
Via Benzinga
News headline image
Botensilimab/Balstilimab Data in MSS CRC Selected for the American Society of Clinical Oncology 2024 Annual Meeting
From Agenus Inc.
Via Business Wire
News headline image
Top 2 Health Care Stocks Which Could Rescue Your Portfolio This Month ↗
 
Via Benzinga
News headline image
Agenus to Provide First Quarter 2024 Financial Report and Corporate Update
From Agenus Inc.
Via Business Wire
News headline image
Why JPMorgan Shares Are Trading Lower By Around 5%? Here Are Other Stocks Moving In Friday's Mid-Day Session ↗
Shares of JPMorgan Chase & Co. (NYSE: JPM) fell sharply during Friday’s session following first-quarter earnings. 
Via Benzinga
News headline image
Small-Cap Cancer Drug Developer Agenus' Highlights Encouraging Data From Colorectal Cancer, But Funding Concerns Loom ↗
The latest Phase 1 trial results of Agenus' botensilimab and balstilimab (BOT/BAL) combination therapy for metastatic CRC showcase promising clinical activity. 
Via Benzinga
News headline image
Agenus Announces Updated Phase 1 Data and Progress on BOT/BAL Development in Metastatic MSS Colorectal Cancer
From Agenus Inc.
Via Business Wire
News headline image
Gold Moves Higher; Auddia Shares Surge ↗
U.S. stocks traded higher toward the end of trading, with the Nasdaq Composite gaining around 0.1% on Monday. The Dow traded up 0.04% to 38,919.32 while the NASDAQ rose 0.11% to 16,266.07. The S&P 500... 
Via Benzinga
Topics Stocks
News headline image
12 Health Care Stocks Moving In Monday's Intraday Session ↗
 
Via Benzinga
News headline image
Why Agenus Shares Are Trading Lower By Around 17%? Here Are Other Stocks Moving In Monday's Mid-Day Session ↗
Shares of Agenus Inc. (NASDAQ: AGEN) fell sharply during Monday’s session. Agenus disclosed a 1-for-20 reverse stock split of common stock. Agenus Inc. (NASDAQ: AGEN) declined 17% to $0.4181 on... 
Via Benzinga
News headline image
Crude Oil Moves Lower; Perion Network Shares Tumble ↗
U.S. stocks traded higher midway through trading, with the Nasdaq Composite gaining over 50 points on Monday. The Dow traded up 0.21% to 38,983.94 while the NASDAQ rose 0.39% to 16,311.32. The S&P 500... 
Via Benzinga
Topics Stocks
News headline image
Today’s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Monday ↗
It's time to start the trading week with a breakdown of the biggest pre-market stock movers worth watching on Monday morning! 
Via InvestorPlace
News headline image
Down 75%. Is Agenus Stock a Buy on the Dip? ↗
Wall Street analysts who watch the cancer drug developer closely think it could rocket higher. 
Via The Motley Fool
News headline image
RADCOM, Lotus Technology And 3 Stocks To Watch Heading Into Monday ↗
With U.S. stock futures trading lower this morning on Monday, some of the stocks that may grab investor focus today are as follows: 
Via Benzinga
News headline image
Agenus Announces Reverse Stock Split of Common Stock
From Agenus Inc.
Via Business Wire
News headline image
2 Stocks That Could More Than Double Your Money, According to Wall Street: Are They Buys Now? ↗
These stocks could rocket higher, but they also present significant risks. 
Via The Motley Fool
News headline image
3 Mind-Blowing Stocks That Could Turn $1,000 Into $1 Million ↗
If you want the chance at possible absurd returns, then consider gambling on these stocks to turn $1,000 into $1 million. 
Via InvestorPlace
News headline image
Agenus (AGEN) Q4 2023 Earnings Call Transcript ↗
AGEN earnings call for the period ending December 31, 2023. 
Via The Motley Fool
Topics Earnings
News headline image
Agenus Reports Fourth Quarter and Full Year 2023 Results
From Agenus Inc.
Via Business Wire
News headline image
Agenus Announces Preclinical Data on BMS-986442 (AGEN1777) at AACR 2024
From Agenus Inc.
Via Business Wire
News headline image
Earnings Scheduled For March 14, 2024 ↗
Companies Reporting Before The Bell • Pharming (NASDAQ:PHAR) is projected to report earnings for its fourth quarter. 
Via Benzinga
< Previous 1 2
...
5 6 7 8 9 10 11 12 Next >
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.
© 2025 FinancialContent. All rights reserved.
B. Riley Financial's diverse suite of services goes beyond traditional financial service offerings. By leveraging cross-platform expertise and assets, B. Riley Financial companies are uniquely positioned to provide full service, collaborative solutions to our clients at every stage of the business life cycle and in all market conditions.

B. Riley refers to B. Riley Financial, Inc. and/or one or more of its subsidiaries or affiliates. Click here for further details.